Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

SHE:002900 Revenue

Harbin Medisan Pharmaceutical had revenue of 228.84M CNY in the quarter ending March 31, 2026, with 11.61% growth. This brings the company's revenue in the last twelve months to 813.23M, down -25.44% year-over-year. In the year 2025, Harbin Medisan Pharmaceutical had annual revenue of 789.42M, down -30.29%.

• Revenue (ttm): 813.23M
• Revenue Growth: -25.44%
• P/S Ratio: 4.40
• Revenue / Employee: 322.45K
• Employees: 2,522
• Market Cap: 3.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	789.42M	-343.05M	-30.29%
Dec 31, 2024	1.13B	-54.31M	-4.58%
Dec 31, 2023	1.19B	158.37M	15.40%
Jan 1, 2023	1.03B	82.61M	8.73%
Jan 1, 2022	945.80M	-393.08M	-29.36%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error